TrialJournal of acquired immune deficiency syndromes (1999)2011

Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.

J Nomthandazo Dlamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.